Changes in constipation severity and gut microbiota after lactulose administration in patients with chronic constipation: A prospective single-arm interventional study

BACKGROUND: Lactulose is an osmotic laxative that may affect gut microbiota through its prebiotic properties. However, few studies have evaluated the changes in clinical symptoms and gut microbiota before and after lactulose administration in patients with chronic constipation. We aimed to evaluate the changes in constipation symptoms and gut microbiota after 8 weeks of lactulose administration in patients with chronic constipation. METHODS: This prospective single-arm interventional study included 19 Japanese patients with chronic constipation who were enrolled between April 2019 and December 2024. Lactulose was administered for 8 weeks. The prespecified primary outcome was the change in mean weekly spontaneous bowel movement frequency from baseline to week 8. Secondary outcomes included defecation status, constipation severity assessed using the Constipation Scoring System (CSS), gastrointestinal symptoms assessed using the Gastrointestinal Symptom Rating Scale (GSRS), blood test results, and fecal gut microbiota. Gut microbiota analysis was performed using QIIME2. Nonparametric statistical methods were used, with adjustment for multiple comparisons where appropriate. RESULTS: The prespecified primary outcome, the change in mean weekly spontaneous bowel movement frequency from baseline to week 8, showed no statistically significant difference. No significant changes were observed in overall bowel movement frequency, Bristol Stool Form Scale score, or rescue medication use. After Holm adjustment, significant differences across the 3 time points were observed in the CSS item scores for frequency of bowel movements and time needed per attempt, as well as in the total CSS score. In the GSRS, numerically lower scores were observed in abdominal pain and hard stool scores, but no GSRS item remained statistically significant after Holm adjustment. Gut microbiota analysis showed a significant increase in the relative abundance of Bifidobacteriales. The Simpson index decreased significantly, and weighted UniFrac analysis showed a significant compositional difference between baseline and week 8. No serious adverse events or clinically relevant abnormalities in laboratory test results were observed. CONCLUSION: Lactulose administration was associated with improvements in selected measures of constipation severity and compositional changes in the gut microbiota, particularly an increase in the relative abundance of Bifidobacteriales.

Authors

Institutions

Publication Details

Journal
Medicine
Published
2026-11-13
DOI
https://doi.org/10.1097/md.0000000000051526
Primary Topic
Gastrointestinal motility and disorders
Type
article
Field-Weighted Citation Impact
0.00
Controls
|||
ALL TIME
JAN
FEB
MAR
APR
MAY
JUN
JUL
AUG
SEP
OCT
NOV
article

Changes in constipation severity and gut microbiota after lactulose administration in patients with chronic constipation: A prospective single-arm interventional study

Naotaka Ogasawara, Masahide Ebi, Tatsuya Kawamura, Kunio Kasugai et al.
Medicine
Gastrointestinal motility and disorders
article

Changes in constipation severity and gut microbiota after lactulose administration in patients with chronic constipation: A prospective single-arm interventional study

Naotaka Ogasawara, Masahide Ebi, Tatsuya Kawamura, Kunio Kasugai, Satoshi Ono, Yoshiharu Yamaguchi, Masanao Nakamura, Makoto Sasaki, Shunsuke Kato, Takashi Tashiro, Kazunori Adachi, Akane Sugimura, Hitoshi Tanaka
article en

Abstract

BACKGROUND: Lactulose is an osmotic laxative that may affect gut microbiota through its prebiotic properties. However, few studies have evaluated the changes in clinical symptoms and gut microbiota before and after lactulose administration in patients with chronic constipation. We aimed to evaluate the changes in constipation symptoms and gut microbiota after 8 weeks of lactulose administration in patients with chronic constipation. METHODS: This prospective single-arm interventional study included 19 Japanese patients with chronic constipation who were enrolled between April 2019 and December 2024. Lactulose was administered for 8 weeks. The prespecified primary outcome was the change in mean weekly spontaneous bowel movement frequency from baseline to week 8. Secondary outcomes included defecation status, constipation severity assessed using the Constipation Scoring System (CSS), gastrointestinal symptoms assessed using the Gastrointestinal Symptom Rating Scale (GSRS), blood test results, and fecal gut microbiota. Gut microbiota analysis was performed using QIIME2. Nonparametric statistical methods were used, with adjustment for multiple comparisons where appropriate. RESULTS: The prespecified primary outcome, the change in mean weekly spontaneous bowel movement frequency from baseline to week 8, showed no statistically significant difference. No significant changes were observed in overall bowel movement frequency, Bristol Stool Form Scale score, or rescue medication use. After Holm adjustment, significant differences across the 3 time points were observed in the CSS item scores for frequency of bowel movements and time needed per attempt, as well as in the total CSS score. In the GSRS, numerically lower scores were observed in abdominal pain and hard stool scores, but no GSRS item remained statistically significant after Holm adjustment. Gut microbiota analysis showed a significant increase in the relative abundance of Bifidobacteriales. The Simpson index decreased significantly, and weighted UniFrac analysis showed a significant compositional difference between baseline and week 8. No serious adverse events or clinically relevant abnormalities in laboratory test results were observed. CONCLUSION: Lactulose administration was associated with improvements in selected measures of constipation severity and compositional changes in the gut microbiota, particularly an increase in the relative abundance of Bifidobacteriales.

MedicineVol. 105(46)
Aichi Medical University (JP)
Good health and well-being
Gastrointestinal motility and disorders
AI Navigator

Ask Laika to Summarize, Analyze, and Connect papers live on the map.

Summarize Papers & Methodologies

Extract key findings, datasets, and comparative methods across publications.

Benchmark Rankings & Visual Analytics

Rank top research institutions, authors, funders, topics, and journals by Field-Weighted Citation Impact (FWCI) and paper volume with instant charts.

Connect Distant Disciplines

Bridge topological clusters on the map to find hidden collaborative intersections.

Laika access coming soon